29 research outputs found

    GC-MS Determination and Identification of Eleven Fatty Acids in Triglycerides Isolated from the Seeds of Traditional Kurdish Medicinal Plant Anchusa azurea Mill.

    Get PDF
    Anchusa azurea Mill. is naturally grown in Iraqi Kurdistan, and it belongs to the Boraginaceae family. The species A. azurea is eaten by Kurdish people and from a phytochemical point of view it has been almost neglected so far and it was thus considered worthy of study. In this investigation the lipids were extracted from seeds and leaves of A. azurea plant with petroleum ether, followed by chloroform and methanol using soxhlet apparatus. The lipid percentage from seeds and leaves were (7.03%) and (1.17%) respectively. Preliminary work on the first extract allowed for the isolation of a mixture of triglycerides, which were submitted to hydrolysis, followed by methylation of free fatty acids. GC-MS analysis showed that the main components were oleic, palmitic, palmitoleic, 11-eicosenoic, erucic and two ω-9 acids. Totally, eleven fatty acids were analyzed from the seeds of the studied plant using GC-MS analysis. The results showed that the plant seeds contain high percentage of elaidic acid (46.42%), palmitic acid (18.9%), linoleic acid (14.59%), and the other main fatty acids (FAs) are erucic acid (6.33%), 11-eicosenoic acid (5.02%), stearic acid (4.55%) and 6,9,12-octadecatrienoic acid (2.43%). The percentage of minor FAs is (0.78%) nervonic acid, (0.46%) myristic acid, (0.38%) palmitoleic acid and (0.14%) for 11-hexadecenoic acid. The total percentages of polyunsaturated (PUFAs), monounsaturated (MUFAs) and saturated fatty acids (SFAs) from the seeds of A. azurea are (17.02, 59.07, 23.91%) respectively. It was found that the percentage and type of fatty acid constituents from A. azurea seeds oil in the present study varied from the same plant in other places and countries

    An Unprecedented High Content of the Bioactive Flavone Tricin in Huperzia Medicinal Species Used by the Saraguro in Ecuador.

    Get PDF
    The flavone tricin (5,7,4′-trihydroxy-3′,5′-dimethoxyflavone) is considered to be a selective potent inhibitor of different cancer cell lines and a potential colorectal cancer chemopreventive agent. In this paper we describe a reliable UHPLC-UV-ESIMS method for the determination of tricin in Huperzia plants used in the traditional medicine of the Saraguro community living in Southern Ecuador. An unusually high amount of tricin was found in H. brevifolia and H. compacta, which exceeded the content of this flavone determined so far in other plants

    Stima dei danni da vento ai soprassuoli forestali in Regione Toscana a seguito dell'evento del 5 marzo 2015

    Get PDF
    Il vento è uno dei maggiori fattori di disturbo per le foreste europee e i cambiamenti climatici hanno provocato un aumento di eventi estremi negli ultimi anni. La regione Toscana tra il 4 e il 5 marzo 2015 è stata colpita da una tempesta di vento che ha provocato notevoli danni ai soprassuoli forestali. L’obiettivo di questo lavoro è di sviluppare una metodologia speditiva per la mappatura delle aree danneggiate in termini di superfici interessate, numero di piante atterrate e volume legnoso a terra. Il contributo illustra a tal fine l’utilizzo di dati telerilevati e in particolare le potenzialità dei dati Airborne Laser Scanning (ALS)

    Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP

    Get PDF
    Several papers authored by international experts have proposed recommendations on the management of BCR-ABL1+ chronic myeloid leukemia (CML). Following these recommendations, survival of CML patients has become very close to normal. The next, ambitious, step is to bring as many patients as possible into a condition of treatment-free remission (TFR). The Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA; Italian Group for Hematologic Diseases of the Adult) CML Working Party (WP) has developed a project aimed at selecting the treatment policies that may increase the probability of TFR, taking into account 4 variables: the need for TFR, the tyrosine kinase inhibitors (TKIs), the characteristics of leukemia, and the patient. A Delphi-like method was used to reach a consensus among the representatives of 50 centers of the CML WP. A consensus was reached on the assessment of disease risk (EUTOS Long Term Survival [ELTS] score), on the definition of the most appropriate age boundaries for the choice of first-line treatment, on the choice of the TKI for first-line treatment, and on the definition of the responses that do not require a change of the TKI (BCR-ABL1 6410% at 3 months, 641% at 6 months, 640.1% at 12 months, 640.01% at 24 months), and of the responses that require a change of the TKI, when the goal is TFR (BCR-ABL1 >10% at 3 and 6 months, >1% at 12 months, and >0.1% at 24 months). These suggestions may help optimize the treatment strategy for TFR

    Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy

    Get PDF
    IMPORTANCE Delays in screening programs and the reluctance of patients to seek medical attention because of the outbreak of SARS-CoV-2 could be associated with the risk of more advanced colorectal cancers at diagnosis. OBJECTIVE To evaluate whether the SARS-CoV-2 pandemic was associated with more advanced oncologic stage and change in clinical presentation for patients with colorectal cancer. DESIGN, SETTING, AND PARTICIPANTS This retrospective, multicenter cohort study included all 17 938 adult patients who underwent surgery for colorectal cancer from March 1, 2020, to December 31, 2021 (pandemic period), and from January 1, 2018, to February 29, 2020 (prepandemic period), in 81 participating centers in Italy, including tertiary centers and community hospitals. Follow-up was 30 days from surgery. EXPOSURES Any type of surgical procedure for colorectal cancer, including explorative surgery, palliative procedures, and atypical or segmental resections. MAIN OUTCOMES AND MEASURES The primary outcome was advanced stage of colorectal cancer at diagnosis. Secondary outcomes were distant metastasis, T4 stage, aggressive biology (defined as cancer with at least 1 of the following characteristics: signet ring cells, mucinous tumor, budding, lymphovascular invasion, perineural invasion, and lymphangitis), stenotic lesion, emergency surgery, and palliative surgery. The independent association between the pandemic period and the outcomes was assessed using multivariate random-effects logistic regression, with hospital as the cluster variable. RESULTS A total of 17 938 patients (10 007 men [55.8%]; mean [SD] age, 70.6 [12.2] years) underwent surgery for colorectal cancer: 7796 (43.5%) during the pandemic period and 10 142 (56.5%) during the prepandemic period. Logistic regression indicated that the pandemic period was significantly associated with an increased rate of advanced-stage colorectal cancer (odds ratio [OR], 1.07; 95%CI, 1.01-1.13; P = .03), aggressive biology (OR, 1.32; 95%CI, 1.15-1.53; P < .001), and stenotic lesions (OR, 1.15; 95%CI, 1.01-1.31; P = .03). CONCLUSIONS AND RELEVANCE This cohort study suggests a significant association between the SARS-CoV-2 pandemic and the risk of a more advanced oncologic stage at diagnosis among patients undergoing surgery for colorectal cancer and might indicate a potential reduction of survival for these patients

    How future surgery will benefit from SARS-COV-2-related measures: a SPIGC survey conveying the perspective of Italian surgeons

    Get PDF
    COVID-19 negatively affected surgical activity, but the potential benefits resulting from adopted measures remain unclear. The aim of this study was to evaluate the change in surgical activity and potential benefit from COVID-19 measures in perspective of Italian surgeons on behalf of SPIGC. A nationwide online survey on surgical practice before, during, and after COVID-19 pandemic was conducted in March-April 2022 (NCT:05323851). Effects of COVID-19 hospital-related measures on surgical patients' management and personal professional development across surgical specialties were explored. Data on demographics, pre-operative/peri-operative/post-operative management, and professional development were collected. Outcomes were matched with the corresponding volume. Four hundred and seventy-three respondents were included in final analysis across 14 surgical specialties. Since SARS-CoV-2 pandemic, application of telematic consultations (4.1% vs. 21.6%; p < 0.0001) and diagnostic evaluations (16.4% vs. 42.2%; p < 0.0001) increased. Elective surgical activities significantly reduced and surgeons opted more frequently for conservative management with a possible indication for elective (26.3% vs. 35.7%; p < 0.0001) or urgent (20.4% vs. 38.5%; p < 0.0001) surgery. All new COVID-related measures are perceived to be maintained in the future. Surgeons' personal education online increased from 12.6% (pre-COVID) to 86.6% (post-COVID; p < 0.0001). Online educational activities are considered a beneficial effect from COVID pandemic (56.4%). COVID-19 had a great impact on surgical specialties, with significant reduction of operation volume. However, some forced changes turned out to be benefits. Isolation measures pushed the use of telemedicine and telemetric devices for outpatient practice and favored communication for educational purposes and surgeon-patient/family communication. From the Italian surgeons' perspective, COVID-related measures will continue to influence future surgical clinical practice
    corecore